A. Samer Al-Homsi, MD, MBA, an internationally known leader in hematology, has been appointed as system chief of blood and marrow transplant and cellular therapy at the Northwell Health Cancer Institute, which treats more New York residents for cancer than any other provider in the state*. He will also serve as director of faculty and academic affairs in medical oncology at the Cancer Institute.
In his new position, Dr. Al-Homsi’s clinical responsibilities include treating people with blood cancers, including leukemia, lymphoma and multiple myeloma, and benign bone marrow failures disorders with a focus on blood and marrow transplant and cellular therapy. As system chief, he will oversee the growth of the Cancer Institute’s existing Blood and Marrow Transplant Program and guide the transfer of the inpatient units and facilities from North Shore University Hospital in Manhasset to Long Island Jewish (LIJ) Medical Center in New Hyde Park, the home of the R.J. Zuckerberg Cancer Hospital, the only cancer hospital on Long Islan
“Dr. Al-Homsi is a distinguished clinical investigator and leader whose expertise will rapidly expand our ability to provide comprehensive, multidisciplinary care within our Blood and Marrow Transplant Program and facilitate the development of novel cellular therapies to treat patients with both hematologic and solid tumor malignancies,” said Richard Barakat, MD, MBA, physician-in-chief and executive director of the Northwell Health Cancer Institute. “His expertise and vision will be critical to the growth of the Northwell Cancer Institute and the integration of our Blood and Marrow Transplant and Cellular Therapy Program as a central element of the R.J. Zuckerberg Cancer Hospital. In addition, he will continue to lead cutting-edge research, working with the Feinstein Institutes for Medical Research to make the therapies he provides both safer and more effective.”
